Literature DB >> 25340834

Bacterial glycosidases in pathogenesis and glycoengineering.

Jonathan Sjögren1, Mattias Collin.   

Abstract

Glycosylation is a common post-translational protein modification and many key proteins of the immune system are glycosylated. As the true experts of our immune system, pathogenic bacteria produce enzymes that can modify the carbohydrates (glycans) of the defense mechanisms in order to favor bacterial survival and persistence. At the intersection between bacterial pathogenesis and glycobiology, there is an increased interest in studying the bacterial enzymes that modify the protein glycosylation of their colonized or infected hosts. This is of great importance in order to fully understand bacterial pathogenesis, but it also presents itself as a valuable source for glycoengineering and glycoanalysis tools. This article highlights the role of bacterial glycosidases during infections, introduces the use of such enzymes as glycoengineering tools and discusses the potential of further studies in this emerging field.

Entities:  

Keywords:  IgG; bacterial pathogenesis; glycoengineering; glycosidases; glycosylation

Mesh:

Substances:

Year:  2014        PMID: 25340834     DOI: 10.2217/fmb.14.71

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  16 in total

1.  N-glycosylation critically regulates function of oxalate transporter SLC26A6.

Authors:  R Brent Thomson; Claire L Thomson; Peter S Aronson
Journal:  Am J Physiol Cell Physiol       Date:  2016-09-28       Impact factor: 4.249

2.  Immunoglobulin A Glycosylation and Its Role in Disease.

Authors:  Alyssa L Hansen; Colin Reily; Jan Novak; Matthew B Renfrow
Journal:  Exp Suppl       Date:  2021

3.  Genomic Landscape of Ornithobacterium rhinotracheale in Commercial Turkey Production in the United States.

Authors:  Emily A Smith; Elizabeth A Miller; Bonnie P Weber; Jeannette Munoz Aguayo; Cristian Flores Figueroa; Jared Huisinga; Jill Nezworski; Michelle Kromm; Ben Wileman; Timothy J Johnson
Journal:  Appl Environ Microbiol       Date:  2020-05-19       Impact factor: 4.792

4.  Structural basis for the specific cleavage of core-fucosylated N-glycans by endo-β-N-acetylglucosaminidase from the fungus Cordyceps militaris.

Authors:  Haruka Seki; Yibo Huang; Takatoshi Arakawa; Chihaya Yamada; Takashi Kinoshita; Shogo Iwamoto; Yujiro Higuchi; Kaoru Takegawa; Shinya Fushinobu
Journal:  J Biol Chem       Date:  2019-09-23       Impact factor: 5.157

5.  Identification and characterization of a core fucosidase from the bacterium Elizabethkingia meningoseptica.

Authors:  Tiansheng Li; Mengjie Li; Linlin Hou; Yameng Guo; Lei Wang; Guiqin Sun; Li Chen
Journal:  J Biol Chem       Date:  2017-12-01       Impact factor: 5.157

6.  EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans.

Authors:  Jonathan Sjögren; Eoin F J Cosgrave; Maria Allhorn; Maria Nordgren; Stephan Björk; Fredrik Olsson; Sarah Fredriksson; Mattias Collin
Journal:  Glycobiology       Date:  2015-07-08       Impact factor: 4.313

7.  Dysbiosis May Trigger Autoimmune Diseases via Inappropriate Post-Translational Modification of Host Proteins.

Authors:  Aaron Lerner; Rustam Aminov; Torsten Matthias
Journal:  Front Microbiol       Date:  2016-02-05       Impact factor: 5.640

8.  CP40 from Corynebacterium pseudotuberculosis is an endo-β-N-acetylglucosaminidase.

Authors:  Azadeh Shadnezhad; Andreas Naegeli; Mattias Collin
Journal:  BMC Microbiol       Date:  2016-11-08       Impact factor: 3.605

9.  Peptidoglycan Recognition Protein 3 Does Not Alter the Outcome of Pneumococcal Pneumonia in Mice.

Authors:  Anshu Shrivastav; Alexander N Dabrowski; Claudia Conrad; Nelli Baal; Holger Hackstein; Stephanie Plog; Kristina Dietert; Achim D Gruber; Philippe D N'Guessan; Sahar Aly; Norbert Suttorp; Janine Zahlten
Journal:  Front Microbiol       Date:  2018-02-01       Impact factor: 5.640

Review 10.  Design, challenge, and promise of stimuli-responsive nanoantibiotics.

Authors:  Julius A Edson; Young Jik Kwon
Journal:  Nano Converg       Date:  2016-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.